You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 68 No. 6, December 1953 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

ASTEROL TREATMENT OF SUPERFICIAL DERMATOMYCOSES DUE TO T. MENTAGROPHYTES AND T. PURPUREUM

EDMOND EDELSON, M.D.; AARON H. HASKIN, M.D., M.P.H.; Dr. William B. Ignatoff; Edith Titsworth, B.S.

AMA Arch Derm Syphilol. 1953;68(6):627-630.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IN TWO previous papers1 we have reported our experience with Asterol dihydrochloride (2-dimethylamino-6-[beta-diethylaminoethoxy] benzothiazole) in tinea capitis due to Microsporum audouini. One of these communications1b also describes our results with this antifungal agent in cases of moniliasis and of tinea versicolor.

We have since studied the effectiveness of Asterol dihydrochloride in superficial mycological infections due to Trichophyton mentagrophytes and Trichophyton rubrum (purpureum), and our findings are herewith reported.

DERMATOMYCOSES DUE TO T. MENTAGROPHYTES

Thirty-nine patients with superficial fungus infections were studied, in all of whom T. mentagrophytes was culturally determined as the causative organism. As is shown in Table 1, listing the distribution of the areas of involvement and the results obtained, about two-thirds of these patients had infections in the acute phase and one-third in the chronic phase.

The patients with acute infections were first treated, depending on the area of involvement, with foot baths or . . . [Full Text PDF of this Article]


Author Affiliations

NEWARK, N. J.

From the Department of Dermatology and Syphilology, Newark Board of Health Clinics.


Footnotes

The Asterol preparations used in this study were supplied by Hoffmann-La Roche Inc., Nutley, N. J., through the cooperation of Dr. Leo A. Pirk.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1953 American Medical Association. All Rights Reserved.